N.º de artículoEO-5320-200X-1.2

CDC BFR Spiking Standard (¹³C₁₂, 99%) 200X stock in nonane/toluene

HazardousImage
Sinónimos
FórmulaNA
CAS Número LebeledNA
CAS Número UnlabeledNA
Número CE

Propiedades

Peso molecularNA
Pureza98%
FormularioMixture
ConcentraciónSolution
Aplicación(es)Environmental Analysis, Flame Retardants
Temperatura de almacenamientoStore at room temperature away from light and moisture.

Información de seguridad

Hazard Pictograms
HazardousImageHazardousImageHazardousImage
Signal WordDanger
Hazard StatementHighly flammable liquid and vapour., May be fatal if swallowed and enters airways., Causes skin irritation., Causes serious eye irritation., Harmful if inhaled., May cause drowsiness or dizziness., Suspected of causing cancer (Dermal, Inhalation, oral)., Suspected of damaging fertility or the unborn child (Dermal, Inhalation, oral)., May cause damage to organs through prolonged or repeated exposure (Dermal, Inhalation, oral)., Toxic to aquatic life

Comentarios (0)

Todavía no hay comentarios.

N.º de artículoEO-5320-200X-1.2

CDC BFR Spiking Standard (¹³C₁₂, 99%) 200X stock in nonane/toluene

HazardousImage
No description
Sinónimos
FórmulaNA
CAS Número LebeledNA
CAS Número UnlabeledNA
Número CE

Propiedades

Peso molecularNA
Pureza98%
FormularioMixture
ConcentraciónSolution
Aplicación(es)Environmental Analysis, Flame Retardants
Temperatura de almacenamientoStore at room temperature away from light and moisture.

Información de seguridad

Hazard Pictograms
HazardousImageHazardousImageHazardousImage
Signal WordDanger
Hazard StatementHighly flammable liquid and vapour., May be fatal if swallowed and enters airways., Causes skin irritation., Causes serious eye irritation., Harmful if inhaled., May cause drowsiness or dizziness., Suspected of causing cancer (Dermal, Inhalation, oral)., Suspected of damaging fertility or the unborn child (Dermal, Inhalation, oral)., May cause damage to organs through prolonged or repeated exposure (Dermal, Inhalation, oral)., Toxic to aquatic life

Comentarios (0)

Todavía no hay comentarios.